You searched for "intervention"

2994 results found

Moving towards implanting children below 12 months of age

Newborn hearing screening has ensured that deaf infants are identified soon after birth so that habilitation can begin as early as possible. Cochlear implantation is a key component of early intervention for some children, but it is often not performed...

Complications associated with intra-tympanic steroid injections for sudden sensorineural hearing loss

Around 15,000 people in the UK experience a sudden sensorineural hearing loss (SSNHL) each year, and in the majority of cases the cause is unknown. Treatment options for idiopathic SSNHL include various modalities of steroid treatments which have known limitations...

Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL

Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...

Bell’s palsy – antivirals and steroids for all?

The role of antiviral medications in the treatment of Bell’s palsy remains somewhat controversial. Antivirals alone do not appear to be helpful, whereas numerous studies have shown that corticosteroids improve the chance of a full recovery compared to placebo. What...

Temperature-controlled radiofrequency treatment of the nasal valve confers sustained benefit

Aiming to investigate long-term efficacy and safety (three years post treatment), this was an extension of a previous multicentre, prospective, single-blinded, randomised controlled trial that investigated the effectiveness and safety of temperature-controlled radiofrequency treatment (TCRF) to the nasal valve (NV)...

BIOHIT HealthCare to host symposium on gastric cancer at BSG LIVE'24

BIOHIT HealthCare is attending BSG LIVE'24 at ICC Birmingham from the 17th to the 20th of June, where it will be showcasing its broad range of gastrointestinal diagnostic solutions.

Cochlear implant care: putting patients in charge

Should patients take charge of their own cochlear implant care? Helen Cullington presents a compelling case that will provoke discussion in implant centres. Around 1400 people receive a cochlear implant in the UK each year. Patients require lifetime annual follow-up...

Sit back, relax and enjoy the flight! & Arrivals

This series of stories is dedicated to those of you with whom some of these moments were shared (or endured) and, above all, to my amazing and long-suffering husband, David Howard. Most of you know him as an exceptional head...

Otoacoustic emissions in the diagnostic test battery for hearing loss

So, they are great for screening, but how can otoacoustic emissions be integrated into the diagnostic test battery? Beth Prieve examines the role of diagnostic OAEs by asking three simple questions. Audiologists and otolaryngologists are familiar with otoacoustic emissions (OAEs)...

EVOTION: Big data supporting public health policies for hearing loss

Big Data? Biosensors, smart hearing aids and smartphones? The EVOTION Project has it all and more! What will this project tell us about the future of hearing management? Doris-Eva Bamiou, Giorgos Dritsakis and Louisa Murdin, members of the EVOTION team,...

KARL STORZ Promotes Medical Training Worldwide

KARL STORZ has a tradition of promoting the further training of doctors across a broad medical spectrum.

Current management of unilateral sporadic vestibular schwannoma

Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.